The Congress of Peru Thursday approved a bill that authorizes the medicinal and therapeutic use of cannabis and its derivatives in the country.
The proposal received 67 votes in favor, 5 against and 3 abstained of the full legislative, which allowed the bill to be enacted by the executive without going through the second voting session as required by law.
The bill will legalize the medicinal use of marijuana and its derivatives, such as cannabis oil, to alleviate the symptoms of diseases such as cancer, epilepsy and Parkinson’s disease.
Congressman Alberto de Belaunde, who was the advocate of the proposal, said that, once the bill is promulgated, the government will have 60 days to work on the regulations.
De Belaunde added that this document must be published in advance so that all citizens will have access to its content and send suggestions and proposals.
“We achieved it. Historic moment for Congress and the country: Legal medicinal cannabis,” De Belaunde wrote on his Twitter account.
The proposal was endorsed Thursday by Congressman Ricardo Narvaez, president of the Congressional Health Commission, which had already approved the project earlier in October. [Read more at Al Dia News]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Watching Santa Ana, California-based Unrivaled Brands (OTCQX: UNRV) compete in this market reminds me of the movie Memento, where memoryless Guy Pearce literally experiences the action unfold along with the rest of us, even though it’s his story and he’s the only one in it living life essentially in reverse. Similarly, and this may indeed…
LOS ANGELES (AP) — The U.S.′ expanding legal marijuana market is helping drive strong sales and profit growth for multistate operators like Trulieve Cannabis Corp. The Quincy, Florida-based company sells cannabis products in 11 states from Arizona to Pennsylvania. It reported $408.9 million in revenue in the first half of this year, an 89% jump…
A new research report from New Frontier Data, Cannabis and Wellness, a New Consumer Paradigm, challenges the existing framework of the cannabis market and expands it from a two-segment medical and adult-use (recreational) market to a three-segment market. In keeping with changing consumer perceptions and lessening social stigmas related to cannabis across age groups, the…
In a sign that Europe’s cannabis market is gaining traction, the Frankfurt-based operator of a website that pairs patients with marijuana-prescribing doctors has closed a seed funding round while adding one of the industry’s biggest-name executives to its board. The Bloomwell Group, a holding company for the marijuana telemedicine platform Algea Care, obtained more than…